Herpesvirus quiescence in neuronal cells IV: Virus activation induced by pituitary adenylate cyclase-activating polypeptide (PACAP) involves the protein kinase A pathway

References

• Arimura A (1992). Pituitary adenylate cyclase-activating polypeptide (PACAP): discovery and current status of research Regul Pept 37: 287–303.
   PubMedGoogle Scholar
• Brass KM, May V (1999). Pituitary adenylate cyclase-activating polypeptides directly stimulate sympathetic neuron neuropeptide Y release through PACi receptor isoform activation of specific intracellular signaling pathways. J Biol Chem 274: 27702–27710.
   Google Scholar
• Cai Y, Xin X, Shim G-J, Mokuno Y, Uehara H, Yamada T, Agui T, Matsumoto K (1997). Pituitary adenylate cy-clase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 produc-tion through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells. Endocrinology 138: 2515–2520.
   Google Scholar
• Cavallaro S, D'Agata V, Guardabasso V, Travali S, Stivala F, Canonico PL (1995). Differentiation induces pituitary adenylate cyclase-activating polypeptide receptor ex-pression in PC-12 cells. Mol Pharmacol 48: 56–62.
   Google Scholar
• Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H (1990). Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthe-sized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethy1]-5-isoquinolinesulfonamide (H-89), of PC12D pheochro-mocytoma cells. J Biol Chem 265: 5267–5272.
   PubMed Web of Science ®Google Scholar
• Danaher RJ, Jacob RJ, Chorak MD, Freeman CS, Miller CS (1999b). Heat stress induce reactivation of herpes sim-plex virus type 1 from quiescently infected neurally dif-ferentiated PC12 cells. I Neuro Virology 5: 374–383.
   PubMed Web of Science ®Google Scholar
• Danaher RJ, Jacob RJ, Miller CS (1999a). Establishment of a quiescent herpes simplex virus type 1 infection in neu-rally differentiated PC12 cells. I Neuro Virology 5: 258–267.
   PubMed Web of Science ®Google Scholar
• Danaher RJ, Jacob RJ, Miller CS (2000). Herpesvirus qui-escence in neuronal cells: antiviral conditions not re-quired to establish and maintain HSV-2 quiescence. J NeuroVirology 6: 296–302.
   Web of Science ®Google Scholar
• Delgado M, Martinez C, Pozo D, Calvo JR, Leceta J, Ganea D, Gomariz RP (1999). Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6. I Immunol 162: 1200–1205.
   PubMed Web of Science ®Google Scholar
• Deutsch PJ, Sun Y (1992). The 38-amino acid form of pi-tuitary adenylate cyclase-activating polypeptide stimu-lates dual signaling cascades in PC12 cells and promotes neurite outgrowth. J Biol Chem 267: 5108–5113.
   PubMedGoogle Scholar
• DiCicco-Bloom E, Deutsch PJ, Maltzman J, Zhang J, Pintar JE, Zheng J, Friedman WF, Zhou X, Zaremba T (2000). Autocrine expression and ontogenetic functions of the PACAP ligand/receptor system during sympathetic de-velopment. Dev Biol 219: 197–213.
   PubMedGoogle Scholar
• Dickinson T, Fleetwood-Walker SM (1999). VIP and PACAP: very important in pain? Trends Pharmacol Sci 20: 324–329.
   Google Scholar
• Erhardt P, Troppmair J, Rapp UR, Cooper GM (1995). Differ-ential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells. Mol Cell Biol 15: 5524–5530.
   PubMedGoogle Scholar
• Ghatei MA, Takahashi K, Suzuki Y, Gardiner J, Jones PM, Bloom SR (1993). Distribution, molecular characteriza-tion of pituitary adenylate cyclase-activating polypep-tide and its precursor encoding messenger RNA in hu-man and rat tissues. JEndocrino/ 136: 159–166.
   Google Scholar
• Halford WP, Gebhart BM, Carr DJ (1996). Mechanisms of herpes simplex virus type 1 reactivation. I Virol 70: 5051–5060.
   PubMed Web of Science ®Google Scholar
• Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR, Robberecht P, Said SI, Sreed-haran SP, Wank SA, Waschek JA (1998). International
   Google Scholar
• Union of Pharmacology. XVIII. Nomenclature of re-ceptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 50: 265–270.
   Google Scholar
• Huang RD, Smith MF, Zahler WL (1982). Inhibition of forskolin-activated adenylate cyclase by ethanol and other solvents. I Cyclic Nucleotide Res 8: 385–394.
   Google Scholar
• Jordan R, Pepe J, Schaffer PA (1998). Characterization of a nerve growth factor-inducible celluar activity that en-hances herpes simplex virus type 1 gene expression and replication of an ICP0 null mutant in cells of neural lin-eage. J Virol 72: 5373–5382.
   PubMed Web of Science ®Google Scholar
• Lai CC, Wu SY, Lin HH, Dun NJ (1997). Excitatory action of pituitary adenylate cyclase activating polypeptide on rat sympathetic preganglionic neurons in vivo and in vitro. Brain Res 748: 189–194.
   Google Scholar
• Larsen JO, Hannibal J, Knudsen SM, Fahrenkrug J (1997). Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) in the mesencephalic trigeminal nucleus of the rat after transsection of the masseteric nerve. Brain Res Mol Brain Res 46: 109–117.
   Google Scholar
• Lazarovici P, Jiang H, Fink D Jr (1998). The 38-amino-acid form of pituitary adenylate cyclase-activating polypep-tide induces neurite outgrowth in PC12 cells that is de-pendent on protein kinase C and extracellular signal-regulated kinase but not on protein kinase A, nerve growth factor receptor tyrosine kinase, p21(ras) G pro-tein, and pp60(c-src) cytoplasmic tyrosine kinase. Mol Pharmacol 54: 547–558.
   PubMedGoogle Scholar
• May V, Beaudet MM, Parsons RL, Hardwick JC, Gauthier EA, Durda JP, Braas KM (1998). Mechanisms of pitu-itary adenylate cyclase activating polypeptide (PACAP)-induced depolarization of sympathetic superior cervical ganglion (SCG) neurons. Ann NY Acad Sci 865: 164–175.
   Google Scholar
• Miller CS, Danaher RJ, Jacob RJ (1998). Molecular aspects of herpes simplex virus I: latency, reactivation and re-currence. Crit Rev Oral Biol Med 9: 541–562.
   PubMedGoogle Scholar
• Miller CS, Smith KO (1991). Enhanced replication of herpes simplex virus type 1 in human cells. J Dent Res 70: 111–117.
   Google Scholar
• Millhouse S, Wigdahl B. (2000). Molecular circuitry regu-lating herpes simplex virus type 1 latency in neurons. J NeuroVirology 6: 6–24.
   PubMedGoogle Scholar
• Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD, Coy DH (1989). Isolation of a novel 38 residue hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164: 567–574.
   PubMed Web of Science ®Google Scholar
• Miyata A, Jiang L, Dahl RD, Kitada C, Kubo K, Fujin° M, Minamino N, Arimura A (1990). Isolation of a neuropep-tide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 170: 643–648.
   PubMed Web of Science ®Google Scholar
• Moller K, Reimer M, Ekblad E, Hannibal J, Fahrenkrug J, Kanje M, Sundler F (1997). The effects of axotomy and preganglionic denervation on the expression of pitu-itary adenylate cyclase activating polypeptide (PACAP), galanin and PACAP type 1 receptors in the rat superior cervical ganglion. Brain Res 775: 166–182.
   Google Scholar
• Moriya A, Yoshiki A, Kita M, Fushiki S, Imanishi J (1994). Heat shock-induced reactivation of herpes simplex virus type 1 in latently infected mouse trigeminal gan-glion cells in dissociated culture. Arch Virol 135: 419–425.
   Google Scholar
• Nakayama H, Ueno S, Ikeuchi T, Hatanaka H (2000). Regu-lation of alpha3 nicotinic acetylcholine receptor subunit mRNA levels by nerve growth factor and cyclic AMP in PC12 cells. J Neurochem 74: 1346–1354.
   Google Scholar
• Pisegna JR, Wank SA (1993). Molecular cloning and functional expression of the pituitary adenylate cyclase-activatingpolypeptide type I receptor. Proc Nat] Acad Sci USA 90: 6345–6349.
   PubMedGoogle Scholar
• Preston CM (2000). Repression of viral transcription during herpes simplex virus latency. I Gen Virol 81: 1–9.
   PubMed Web of Science ®Google Scholar
• Rydel RE, Greene LA (1988). CAMP-analogs promote sur-vival and neurite outgrowth in cultures of rat sym-pathetic and sensory neurons independently of nerve growth factor. Proc Nat] Acad Sci USA 85: 1257–1261.
   PubMed Web of Science ®Google Scholar
• Sawtell NM, Thompson RL (1992). Rapid in vivo reactiva-tion of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. I Virol 66: 2150–2156.
   PubMed Web of Science ®Google Scholar
• Seamon KB, Daly JW (1981). Activation of adenylate cy-clase by the diterpene forskolin does not require the nucleotide regulatory protein. I Biol Chem 256: 9799–9801.
   Google Scholar
• Smith RL, Pizer LI, Johnson EM Jr, Wilcox CL (1992). Acti-vation of second-messenger pathways reactivates latent herpes simplex virus in neuronal cultures. Virology 188: 311–318.
   Google Scholar
• Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, Journot L (1993). Differential signal trans-duction by five splice variants of the PACAP receptor. Nature 365: 170–175.
   Google Scholar
• Tajti J, Uddman R, Moller S, Fundler F, Edvinsson L (1999). Messenger molecules and receptor mRNA in the human trigeminal ganglion. J A uton Nerv Syst 76: 176–183.
   Google Scholar
• Tanaka J, Koshimura K, Murakami Y, Sohmiya M, Yanaihara N, Kato Y (1997). Neuronal protection from apoptosis by pituitary adenylate cyclase-activating polypeptide. Regulatory Peptides 72: 1–8.
   Google Scholar
• Tanaka K, Shibuya I, Nagamoto T, Yamashita H, Kanno T (1996). Pituitary adenylate cyclase-activating polypep-tide causes rapid Ca2+ release from intracellular stores and long lasting Ca2+ influx mediated by Na + influx-dependent membrane depolarization in bovine adrenal chromaffin cells. Endocrinology 137: 956–966.
   Google Scholar
• Tatsuno I, Yada T, Vigh S, Hidaka H, Arimura A (1992). Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide increase cytosolic free cal-cium concentration in cultured rat hippocampal neu-rons. Endocrino/ogy 131: 73–81.
   Google Scholar
• Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhame L, Charon D, Kirilovsky J (1991). The bisin-dolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. I Biol Chem 266: 15771–15781.
   Web of Science ®Google Scholar
• Way KJ, Chou E, King GL (2000). Identification of PKC-isoform-specific biological actions using pharmacologi-cal approaches. Trends Pharmacol Sci 21: 181–187.
   PubMed Web of Science ®Google Scholar
• Xia K, Knipe DM, DeLuca NA (1996). Role of protein kinase A and the serine-richregion of herpes simplex virus type 1 ICP4 in viral replication. I Virol 70: 1050–1060.
   PubMedGoogle Scholar
• Yada T, Sakurada M, Ihida K, Nakata M, Murata F, Arimura A, Kikuchi M (1994). Pituitary adenylate cyclase activat-ing polypeptide is an extraordinarilypotent intrapancre-atic regulator of insulin secretion from islet beta-cells. J Biol Chem 269: 1290–1293.
   Google Scholar
• Zhang Q Shi T-J, Ji R-R, Sundler F, Hannibal J, Fahrenkrug J, Hokfelt T (1995). Expression of pituitary adenylate cyclase-activatingpolypeptide in dorsal root ganglia fol-lowing axotomy: time course and coexistence. Brain Res 705: 149–158.
   PubMed Web of Science ®Google Scholar
• Zh ang Y, Danielsen N, Sundler F, Mulder H (1998). Pi-tuitary adenylate cyclase-activating peptide is upregu-lated in sensory neurons by inflammation. Ne uroreport 9: 2833–2836.
   Google Scholar